Articles for category: Most Popular

Russ Cohen

Avantis Emerging Markets Equity ETF Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Avantis Emerging Markets Equity ETF (Symbol: AVEM) where we have detected an approximate $1.1 billion dollar inflow — that’s a 5.3% increase week over week in outstanding units (from 230,400,000 to 242,500,000). Among the largest ...

Russ Cohen

Physical AI Is Less Than 3% of Nvidia's Revenue. Here's How It Could Transform Nvidia By 2035.

Key Points Nvidia’s data-center segment is driving virtually all of the company’s results. Nvidia’s Rubin product line is designed to capitalize on agentic artificial intelligence (AI). Compute demand for physical AI is one of Nvidia’s most exciting long-term opportunities. 10 stocks we like better than Nvidia › If you tuned into Nvidia‘s (NASDAQ: NVDA) Feb. ...

Russ Cohen

As Buffett Steps Down as CEO of Berkshire Hathaway, This Trio of His Favorite Stocks Makes Up 45% of the $320 Billion Portfolio

Key Points Apple fans continue to upgrade to new iPhones and buy connecting Apple products. Younger customers are driving growth at American Express, indicating a long growth runway. Coca-Cola pays a growing, reliable dividend and can protect your portfolio under adverse circumstances. 10 stocks we like better than Apple › Greg Abel has already taken ...

Russ Cohen

Nvidia vs. Amazon: Which AI Stock Is a Better Buy Now?

Key Points Nvidia’s data center revenue surged 75% year over year in its most recent quarter. Amazon’s cloud computing segment saw its growth rate accelerate to 24% in Q4. One of these two artificial intelligence winners offers a safer mix of cyclical resilience and margin durability. 10 stocks we like better than Amazon › When ...

Russ Cohen

BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this landscape, bioAffinity Technologies, Inc. BIAF and Guardant Health, Inc. GH represent two distinct approaches to cancer diagnostics and molecular testing. While both companies operate in the broader oncology ...

Russ Cohen

Is Distribution Hitting the S&P 500? What Traders Should Watch Now

Key Takeaways US large caps dipped to multi-month lows this week amid oil’s surge, but dip buyers responded. A subtle sector shift offers some hope for the bulls heading into key earnings reports and macro data. SPY distribution risk and the dollar’s consolidation are potential bellwether indicators. Traders can finally turn away from geopolitics in ...

Russ Cohen

Why CoreWeave Stock Charged Higher on Wednesday

Key Points CoreWeave announced a multiyear deal with Perplexity AI. Perplexity AI will leverage CoreWeave’s neocloud platform to power its AI inference workloads While CoreWeave is growing at a blistering pace, investors should exercise care. 10 stocks we like better than CoreWeave › CoreWeave (NASDAQ: CRWV) stock charged sharply higher today, gaining as much as ...

Russ Cohen

Here's Why Oracle Stock Got Hammered Last Month

Key Points Oracle and OpenAI are burning cash, and there are significant questions around their ability to raise commensurate funds to achieve their aims. Reports of OpenAI clarifying its spending plans are a positive for Oracle stock. 10 stocks we like better than Oracle › Oracle (NYSE: ORCL) declined 11.7% in March according to data ...

Russ Cohen

Netflix Drops Its Deal to Acquire Warner Bros.: What Lies Ahead?

Netflix NFLX stock surged nearly 10% on Feb. 26, 2026, after the streaming giant formally declined to raise its bid for Warner Bros. Discovery‘s WBD studio and streaming assets — a decision that ended what would have been the company’s largest-ever acquisition and handed Paramount Skydance PSKY a clear path to claim the Hollywood legacy ...